Home › Trial NCT07500129
Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer
- Trial IDNCT07500129
- StatusNot Yet Recruiting
- PhaseN/A
- Study typeObservational
- SponsorAtlas University
- Enrollment60
- Start date2026-04-12
- ConditionsBreast Cancer · Invasive Breast Carcinoma · Exosomal microRNA · Neoadjuvant Chemotherapy Response · Pathological Complete Response
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.